Transportation Healthcare Sector

HLS Therapeutics

Market Cap: CA$155.0m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

Kewaunee Scientific

Market Cap: US$111.4m

Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products.

Myomo

Market Cap: US$110.5m

A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.

Kyverna Therapeutics

Market Cap: US$110.2m

Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.

Korro Bio

Market Cap: US$110.2m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.

InfuSystem Holdings

Market Cap: US$109.5m

Through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

Sagimet Biosciences

Market Cap: US$109.5m

A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States.

Achieve Life Sciences

Market Cap: US$109.3m

A clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction.

American Well

Market Cap: US$109.1m

An enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.

Sangamo Therapeutics

Market Cap: US$107.4m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Cibus

Market Cap: US$106.2m

An agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products.

ACC Aviation Holdings

Market Cap: US$106.2m

Focuses on developing canna powder products.

Cardiol Therapeutics

Market Cap: CA$145.5m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Assembly Biosciences

Market Cap: US$105.1m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

Atossa Therapeutics

Market Cap: US$105.0m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

Entasis Therapeutics Holdings

Market Cap: US$104.8m

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States.

MDxHealth

Market Cap: US$104.2m

A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

Caribou Biosciences

Market Cap: US$104.2m

A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.

Microbot Medical

Market Cap: US$102.9m

A clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States.

Vaxart

Market Cap: US$102.6m

A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States.

Happy Belly Food Group

Market Cap: CA$141.1m

Provides food products in Canada.

Invivyd

Market Cap: US$101.7m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

Cassava Sciences

Market Cap: US$101.4m

A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.

Cardiff Lexington

Market Cap: US$101.1m

Operates in the health care industry in the United States.

Milestone Pharmaceuticals

Market Cap: US$100.9m

A biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.

iCAD

Market Cap: US$99.9m

Provides AI-powered cancer detection solutions in the United States.

Cuprina Holdings (Cayman)

Market Cap: US$99.3m

A biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.

Xtant Medical Holdings

Market Cap: US$98.6m

Provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.

4DMedical

Market Cap: AU$153.2m

Operates as a medical technology company in the United States and Australia.

BioSyent

Market Cap: CA$133.9m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Ironwood Pharmaceuticals

Market Cap: US$95.9m

A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.

I-Mab

Market Cap: US$95.5m

A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.

OncoCyte

Market Cap: US$95.2m

Operates as a precision diagnostics company in the United States and internationally.

Cabaletta Bio

Market Cap: US$94.9m

A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.

Nautilus Biotechnology

Market Cap: US$93.7m

A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.

Coya Therapeutics

Market Cap: US$93.7m

A clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs).